About us

AstraZeneca in India

AZPIL

AstraZeneca India was established in 1979 and is headquartered at Bengaluru, Karnataka. AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. It has a workforce of over 1400 employees across the country that is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory.

AZIPL

Rated as one of the finest in South East Asia, AstraZeneca’s Indian manufacturing facility has a sophisticated production facility designed to meet the most stringent international standards, conforming to WHO cGMP (current Good Manufacturing Practices) norms. The facility is an ISO 14001 certified company and has a full-fledged environment management system in place.

AstraZeneca India Private Limited (AZIPL) hosts the IT (Global Technology Centre), Global Business Services (Global Commercial Operations) and GMD (Global Medicines Development). AZIPL is governed by a Board of Directors.

AstraZeneca’s Global Technology Centre (GTC)

AstraZeneca’s Global Technology Centre (GTC) in Chennai, is our primary insourced IT facility delivering significant value to the business through an end-to-end, integrated IT service delivery mode. The centre was set up in September 2014 in Chennai, Tamil Nadu, India with the mandate to deliver best in class IT service for the global business. In a span of 5 years, the centre has grown to 2400+ employees becoming one of the largest pharma technology centres in India and has highly diverse workforce with close to 30% women and people from all over India. Although originally started as an IT Support Centre, AZ Chennai, has today become the engine for our digital journey and a major source of technology innovation.

R&D Bangalore

R&D Bangalore was launched in 2017 to support AstraZeneca’s global established medicines portfolio. The R&D Bangalore team provides support across a range of therapy areas, including oncology, respiratory and cardiovascular and metabolic diseases, with a focus on AstraZeneca’s mature brands which are used by patients around the world. The current team of around 90 employees consists of scientific experts in the fields of regulatory science, clinical science, and patient safety.

The Global Business Services (GBS)

The Global Business Services (GBS), which now houses Global Commercial Operations (GCO), was set up in Chennai in 2017 and in 2 years has driven efficiency across content management, multichannel marketing and analytics and reporting. GCO Global supports E2E commercial content management to markets – from creation, production, review, process, publishing and reporting. GCO helps multiple markets to avoid duplication of content leading to faster launches and cost savings.

All the AstraZeneca units in India, work closely together as one science-led pharmaceutical Organisation supporting the company’s purpose of delivering life changing medicines to patients. The company has been recently certified as a Great Place to Work by Great Place to Work Institute in 2018 and is among the 100 Best companies for Women in India 2018 by Avatar & Working Mothers.

The company maintains a high ethical standard of business practice, promoting its products in a customer focused and value-adding manner, through scientific dissemination of information to the medical fraternity.